Moore DH 2nd - Search Results

1

Activation of the mTOR pathway by low levels of xenoestrogens in breast epithelial cells from high-risk women.

Goodson WH 3rd, Luciani MG, Sayeed SA, Jaffee IM, Moore DH 2nd, Dairkee SH. Goodson WH 3rd, et al. Among authors: moore dh 2nd. Carcinogenesis. 2011 Nov;32(11):1724-33. doi: 10.1093/carcin/bgr196. Epub 2011 Sep 1. Carcinogenesis. 2011. PMID: 21890461 Free PMC article.

2

Optimization of clinical breast examination.

Goodson WH 3rd, Hunt TK, Plotnik JN, Moore DH 2nd. Goodson WH 3rd, et al. Among authors: moore dh 2nd. Am J Med. 2010 Apr;123(4):329-34. doi: 10.1016/j.amjmed.2009.08.023. Am J Med. 2010. PMID: 20362752

3

Screening program reduced melanoma mortality at the Lawrence Livermore National Laboratory, 1984 to 1996.

Schneider JS, Moore DH 2nd, Mendelsohn ML. Schneider JS, et al. Among authors: moore dh 2nd. J Am Acad Dermatol. 2008 May;58(5):741-9. doi: 10.1016/j.jaad.2007.10.648. Epub 2008 Feb 20. J Am Acad Dermatol. 2008. PMID: 18068264

4

Identification of a robust gene signature that predicts breast cancer outcome in independent data sets.

Korkola JE, Blaveri E, DeVries S, Moore DH 2nd, Hwang ES, Chen YY, Estep AL, Chew KL, Jensen RH, Waldman FM. Korkola JE, et al. Among authors: moore dh 2nd. BMC Cancer. 2007 Apr 11;7:61. doi: 10.1186/1471-2407-7-61. BMC Cancer. 2007. PMID: 17428335 Free PMC article.

5

Streamlining clinical breast examination.

Goodson WH 3rd, Grissom NA, Moore DH 2nd, Dirbas FM. Goodson WH 3rd, et al. Among authors: moore dh 2nd. J Natl Cancer Inst. 2005 Oct 5;97(19):1476-7. doi: 10.1093/jnci/dji309. J Natl Cancer Inst. 2005. PMID: 16204698 No abstract available.

6

In utero angiopoietin-2 gene delivery remodels placental blood vessel phenotype: a murine model for studying placental angiogenesis.

Geva E, Ginzinger DG, Moore DH 2nd, Ursell PC, Jaffe RB. Geva E, et al. Among authors: moore dh 2nd. Mol Hum Reprod. 2005 Apr;11(4):253-60. doi: 10.1093/molehr/gah159. Epub 2005 Feb 25. Mol Hum Reprod. 2005. PMID: 15734895

7

Improving efficiency of ALS clinical trials using lead-in designs.

Moore DH 2nd, Miller RG. Moore DH 2nd, et al. Amyotroph Lateral Scler Other Motor Neuron Disord. 2004 Sep;5 Suppl 1:57-60. doi: 10.1080/17434470410019997. Amyotroph Lateral Scler Other Motor Neuron Disord. 2004. PMID: 15512875

8

Patterns of chromosomal alterations in breast ductal carcinoma in situ.

Hwang ES, DeVries S, Chew KL, Moore DH 2nd, Kerlikowske K, Thor A, Ljung BM, Waldman FM. Hwang ES, et al. Among authors: moore dh 2nd. Clin Cancer Res. 2004 Aug 1;10(15):5160-7. doi: 10.1158/1078-0432.CCR-04-0165. Clin Cancer Res. 2004. PMID: 15297420

9

Genetic aberrations in prostate carcinoma detected by comparative genomic hybridization and microsatellite analysis: association with progression and angiogenesis.

Strohmeyer DM, Berger AP, Moore DH 2nd, Bartsch G, Klocker H, Carroll PR, Loening SA, Jensen RH. Strohmeyer DM, et al. Among authors: moore dh 2nd. Prostate. 2004 Apr 1;59(1):43-58. doi: 10.1002/pros.20028. Prostate. 2004. PMID: 14991865

10

Cytology of ductal lavage fluid of the breast.

Ljung BM, Chew KL, Moore DH 2nd, King EB. Ljung BM, et al. Among authors: moore dh 2nd. Diagn Cytopathol. 2004 Mar;30(3):143-50. doi: 10.1002/dc.20003. Diagn Cytopathol. 2004. PMID: 14986293

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results